제이브이엠

054950KOSDAQ

62.0 / 100

Reference Date: 2026-10-23

Financial Score30.5 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 5.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Jevem develops and sells cutting-edge automated pharmacy systems for hospitals and pharmacies, streamlining tasks such as medication management, sorting, distribution, and packaging to enhance pharmaceutical efficiency. Key products include ATDPS, VIZEN EX, WIZER, and INTIPharm, with international expansion supported by partnerships with Hanmi Pharm and Sinopharm.

Number of Employees

322people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

8.84Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

1.12Industry Average 1.204.0Point

In line with industry avg

ROE

13.00Industry Average 8.005.5Point

1.6x industry avg (good)

Debt Ratio

3.18Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.0% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲5.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 14.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 21,750Won52-week high 32,35052-week low 20,000

1-month return2.0Point

1m -5.84% (slight drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-07